Loading...

VITA 34 AG

VTIAFPNK
Healthcare
Medical - Care Facilities
$6.38
$0.00(0.00%)
U.S. Market is Open • 11:45

VITA 34 AG Fundamental Analysis

VITA 34 AG (VTIAF) shows moderate financial fundamentals with a PE ratio of -14.94, profit margin of -7.21%, and ROE of -52.68%. The company generates $0.1B in annual revenue with moderate year-over-year growth of 6.65%.

Key Strengths

Cash Position10.68%
PEG Ratio-0.24

Areas of Concern

ROE-52.68%
Operating Margin-2.63%
Current Ratio0.66
We analyze VTIAF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -48.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-48.2/100

We analyze VTIAF's fundamental strength across five key dimensions:

Efficiency Score

Weak

VTIAF struggles to generate sufficient returns from assets.

ROA > 10%
-3.78%

Valuation Score

Excellent

VTIAF trades at attractive valuation levels.

PE < 25
-14.94
PEG Ratio < 2
-0.24

Growth Score

Moderate

VTIAF shows steady but slowing expansion.

Revenue Growth > 5%
6.65%
EPS Growth > 10%
-4.83%

Financial Health Score

Weak

VTIAF carries high financial risk with limited liquidity.

Debt/Equity < 1
3.30
Current Ratio > 1
0.66

Profitability Score

Weak

VTIAF struggles to sustain strong margins.

ROE > 15%
-5267.61%
Net Margin ≥ 15%
-7.21%
Positive Free Cash Flow
No

Key Financial Metrics

Is VTIAF Expensive or Cheap?

P/E Ratio

VTIAF trades at -14.94 times earnings. This suggests potential undervaluation.

-14.94

PEG Ratio

When adjusting for growth, VTIAF's PEG of -0.24 indicates potential undervaluation.

-0.24

Price to Book

The market values VITA 34 AG at 13.35 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

13.35

EV/EBITDA

Enterprise value stands at 10.65 times EBITDA. This signals the market has high growth expectations.

10.65

How Well Does VTIAF Make Money?

Net Profit Margin

For every $100 in sales, VITA 34 AG keeps $-7.21 as profit after all expenses.

-7.21%

Operating Margin

Core operations generate -2.63 in profit for every $100 in revenue, before interest and taxes.

-2.63%

ROE

Management delivers $-52.68 in profit for every $100 of shareholder equity.

-52.68%

ROA

VITA 34 AG generates $-3.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.78%

Following the Money - Real Cash Generation

Operating Cash Flow

VITA 34 AG generates limited operating cash flow of $3.85M, signaling weaker underlying cash strength.

$3.85M

Free Cash Flow

VITA 34 AG generates weak or negative free cash flow of $-742.91K, restricting financial flexibility.

$-742.91K

FCF Per Share

Each share generates $-0.04 in free cash annually.

$-0.04

FCF Yield

VTIAF converts -0.78% of its market value into free cash.

-0.78%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-14.94

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

13.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.30

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.66

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.53

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How VTIAF Stacks Against Its Sector Peers

MetricVTIAF ValueSector AveragePerformance
P/E Ratio-14.9429.43 Better (Cheaper)
ROE-52.68%684.00% Weak
Net Margin-7.21%-45067.00% (disorted) Weak
Debt/Equity3.300.43 Weak (High Leverage)
Current Ratio0.664.07 Weak Liquidity
ROA-3.78%-17158.00% (disorted) Weak

VTIAF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews VITA 34 AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-4.57%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-311.34%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-67.79%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ